JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4251
iShares US Oil Equipment & Services ETF
IEZ
$347M
| $581K | ﹤0.01% |
36,409
+35,409
| +3,541% | +$667K |
2013 Q2
36 quarters
|
|
4252
Bain Capital Specialty
BCSF
$717M
| $580K | ﹤0.01% |
42,597
+7,951
| +23% | +$119K |
2019 Q2
12 quarters
|
|
4253
CALL
Dynatrace
DT
$17.1B
| $580K | ﹤0.01% |
14,700
-911,000
| -98% | -$36.3M |
2022 Q1
1 quarter
|
|
|
CRNX
4254
DELISTED
Crinetics Pharmaceuticals
CRNX
| $576K | ﹤0.01% |
30,889
-50,847
| -62% | -$1.01M |
2018 Q3
15 quarters
|
|
|
CTRA
4255
CALL
DELISTED
Coterra Energy
CTRA
| $575K | ﹤0.01% |
+22,300
| New | +$676K |
2022 Q2
0 quarters
|
|
4256
Amplitude
AMPL
$1.81B
| $571K | ﹤0.01% |
39,919
+28,647
| +254% | +$503K |
2021 Q3
3 quarters
|
|
4257
CALL
Gran Tierra Energy
GTE
$369M
| $571K | ﹤0.01% |
+49,630
| New | +$790K |
2022 Q2
0 quarters
|
|
|
4258
PUT
Gran Tierra Energy
GTE
$369M
| $571K | ﹤0.01% |
+49,630
| New | +$790K |
2022 Q2
0 quarters
|
|
|
IMTXW
4259
DELISTED
Immatics N.V. Warrants
IMTXW
| – | – |
0
| – | – |
2021 Q1
5 quarters
|
|
4260
Rimini Street
RMNI
$396M
| $571K | ﹤0.01% |
95,115
-54,596
| -36% | -$325K |
2018 Q2
16 quarters
|
|
|
NESR
4261
National Energy Services Reunited Corp
NESR
$2.49B
| $571K | ﹤0.01% |
84,223
-65,627
| -44% | -$478K |
2019 Q1
13 quarters
|
|
|
FNTC
4262
DELISTED
Direxion Daily FinTech Bull 2X Shares
FNTC
| $571K | ﹤0.01% |
50,000
| – | – |
2022 Q1
1 quarter
|
|
4263
Expro Ltd
XPRO
$1.83B
| $568K | ﹤0.01% |
49,271
-22,906
| -32% | -$327K |
2017 Q4
18 quarters
|
|
|
IMGN
4264
DELISTED
Immunogen Inc
IMGN
| $568K | ﹤0.01% |
126,052
+479
| +0.4% | +$2.08K |
2016 Q4
22 quarters
|
|
4265
iShares US Pharmaceuticals ETF
IHE
$1.61B
| $567K | ﹤0.01% |
8,871
-828
| -9% | -$52.6K |
2014 Q1
33 quarters
|
|
|
EMBJ
4266
Embraer S.A. ADS
EMBJ
$13.4B
| $566K | ﹤0.01% |
64,467
+64,161
| +20,968% | +$686K |
2013 Q2
36 quarters
|
|
4267
Hydrofarm Holdings
HYFM
$4.96M
| $566K | ﹤0.01% |
16,279
-5,927
| -27% | -$482K |
2021 Q1
5 quarters
|
|
4268
N-able
NABL
$799M
| $562K | ﹤0.01% |
62,532
+8,144
| +15% | +$79.8K |
2021 Q3
3 quarters
|
|
|
NGMS
4269
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $562K | ﹤0.01% |
41,917
-34,638
| -45% | -$471K |
2021 Q1
5 quarters
|
|
4270
PUT
Canadian Solar
CSIQ
$760M
| $561K | ﹤0.01% |
+18,000
| New | +$553K |
2022 Q2
0 quarters
|
|
4271
MannKind Corp
MNKD
$1.22B
| $556K | ﹤0.01% |
146,108
-1,210
| -0.8% | -$4.45K |
2016 Q4
22 quarters
|
|
|
DCPH
4272
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $556K | ﹤0.01% |
42,247
-321,234
| -88% | -$3.55M |
2017 Q4
18 quarters
|
|
4273
Dianthus Therapeutics
DNTH
$4.93B
| $555K | ﹤0.01% |
28,928
+1,183
| +4% | +$29.2K |
2018 Q3
15 quarters
|
|
4274
ProShares UltraPro S&P 500
UPRO
$5.42B
| $555K | ﹤0.01% |
15,928
-15,335
| -49% | -$715K |
2021 Q1
5 quarters
|
|
4275
YPF Sociedad Anonima ADS
YPF
$19.5B
| $555K | ﹤0.01% |
170,199
-143,003
| -46% | -$617K |
2018 Q4
14 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.